210 related articles for article (PubMed ID: 32912650)
21. Nanotechnologies for biomedical science and translational medicine.
Heath JR
Proc Natl Acad Sci U S A; 2015 Nov; 112(47):14436-43. PubMed ID: 26598663
[TBL] [Abstract][Full Text] [Related]
22. Nanomedicine Approaches for Advanced Diagnosis and Treatment of Atherosclerosis and Related Ischemic Diseases.
Hu B; Boakye-Yiadom KO; Yu W; Yuan ZW; Ho W; Xu X; Zhang XQ
Adv Healthc Mater; 2020 Aug; 9(16):e2000336. PubMed ID: 32597562
[TBL] [Abstract][Full Text] [Related]
23. Functional-DNA-Driven Dynamic Nanoconstructs for Biomolecule Capture and Drug Delivery.
Kim J; Jang D; Park H; Jung S; Kim DH; Kim WJ
Adv Mater; 2018 Nov; 30(45):e1707351. PubMed ID: 30062803
[TBL] [Abstract][Full Text] [Related]
24. Glioblastoma chemotherapeutic agents used in the clinical setting and in clinical trials: Nanomedicine approaches to improve their efficacy.
Aparicio-Blanco J; Sanz-Arriazu L; Lorenzoni R; Blanco-Prieto MJ
Int J Pharm; 2020 May; 581():119283. PubMed ID: 32240807
[TBL] [Abstract][Full Text] [Related]
25. Synthetic Biology: Bottom-Up Assembly of Molecular Systems.
Hirschi S; Ward TR; Meier WP; Müller DJ; Fotiadis D
Chem Rev; 2022 Nov; 122(21):16294-16328. PubMed ID: 36179355
[TBL] [Abstract][Full Text] [Related]
26. Adaptive Polymeric Assemblies for Applications in Biomimicry and Nanomedicine.
Altay Y; Cao S; Che H; Abdelmohsen LKEA; van Hest JCM
Biomacromolecules; 2019 Nov; 20(11):4053-4064. PubMed ID: 31642319
[TBL] [Abstract][Full Text] [Related]
27. Microfluidic-Based Platform for the Evaluation of Nanomaterial-Mediated Drug Delivery: From High-Throughput Screening to Dynamic Monitoring.
Yang Y; Liu S; Geng J
Curr Pharm Des; 2019; 25(27):2953-2968. PubMed ID: 31362686
[TBL] [Abstract][Full Text] [Related]
28. From nanotechnology to nanomedicine: applications to cancer research.
Seigneuric R; Markey L; Nuyten DS; Dubernet C; Evelo CT; Finot E; Garrido C
Curr Mol Med; 2010 Oct; 10(7):640-52. PubMed ID: 20712588
[TBL] [Abstract][Full Text] [Related]
29. Nanotechnology: Revolutionizing the Science of Drug Delivery.
Mishra M; Kumar P; Rajawat JS; Malik R; Sharma G; Modgil A
Curr Pharm Des; 2018; 24(43):5086-5107. PubMed ID: 30727873
[TBL] [Abstract][Full Text] [Related]
30. Nanotechnology and nanomedicine: going small means aiming big.
Teli MK; Mutalik S; Rajanikant GK
Curr Pharm Des; 2010 Jun; 16(16):1882-92. PubMed ID: 20222866
[TBL] [Abstract][Full Text] [Related]
31. Cancer nanomedicine: progress, challenges and opportunities.
Shi J; Kantoff PW; Wooster R; Farokhzad OC
Nat Rev Cancer; 2017 Jan; 17(1):20-37. PubMed ID: 27834398
[TBL] [Abstract][Full Text] [Related]
32. Drug delivery with living cells.
Fliervoet LAL; Mastrobattista E
Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):63-72. PubMed ID: 27129442
[TBL] [Abstract][Full Text] [Related]
33. Functional recruitment for drug delivery through protein-based nanotechnologies.
Vazquez E; Mangues R; Villaverde A
Nanomedicine (Lond); 2016 Jun; 11(11):1333-6. PubMed ID: 27221076
[No Abstract] [Full Text] [Related]
34. Silica nanoparticles as promising drug/gene delivery carriers and fluorescent nano-probes: recent advances.
Liu Y; Lou C; Yang H; Shi M; Miyoshi H
Curr Cancer Drug Targets; 2011 Feb; 11(2):156-63. PubMed ID: 21158720
[TBL] [Abstract][Full Text] [Related]
35. Organ-on-a-Chip: A Preclinical Microfluidic Platform for the Progress of Nanomedicine.
Rodrigues RO; Sousa PC; Gaspar J; Bañobre-López M; Lima R; Minas G
Small; 2020 Dec; 16(51):e2003517. PubMed ID: 33236819
[TBL] [Abstract][Full Text] [Related]
36. Microfluidics for Cancer Nanomedicine: From Fabrication to Evaluation.
Zhang H; Zhu Y; Shen Y
Small; 2018 Jul; 14(28):e1800360. PubMed ID: 29806174
[TBL] [Abstract][Full Text] [Related]
37. The drug delivery field at the inflection point: Time to fight its way out of the egg.
Park K
J Control Release; 2017 Dec; 267():2-14. PubMed ID: 28754609
[TBL] [Abstract][Full Text] [Related]
38. Microfluidics for Artificial Life: Techniques for Bottom-Up Synthetic Biology.
Supramaniam P; Ces O; Salehi-Reyhani A
Micromachines (Basel); 2019 Apr; 10(5):. PubMed ID: 31052344
[TBL] [Abstract][Full Text] [Related]
39. Transforming nanomedicine manufacturing toward Quality by Design and microfluidics.
Colombo S; Beck-Broichsitter M; Bøtker JP; Malmsten M; Rantanen J; Bohr A
Adv Drug Deliv Rev; 2018 Mar; 128():115-131. PubMed ID: 29626549
[TBL] [Abstract][Full Text] [Related]
40. The History of Nanoscience and Nanotechnology: From Chemical-Physical Applications to Nanomedicine.
Bayda S; Adeel M; Tuccinardi T; Cordani M; Rizzolio F
Molecules; 2019 Dec; 25(1):. PubMed ID: 31892180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
